Related Experiment Video
Updated: Jul 4, 2025

Colon Ascendens Stent Peritonitis CASP - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Severe Sepsis Secondary to Toxic Megacolon Revealing an Inflammatory Bowel Disease
Omar Mhammedi Alaoui1,2, Badie Douqchi3,2, Islam Bella2,1
1Intensive Care Unit, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University, Oujda, MAR.
Abstract:
Patients with inflammatory bowel disease can present with numerous infectious complications, including intra-abdominal abscess, perforations of the intestine, fistula formation, and the occurrence of septicemia. Toxic megacolon (TM) is a potentially fatal complication of inflammatory bowel disease (IBD) and is associated with high morbidity and mortality. In this case report, we report a 49-year-old male patient who was admitted to the intensive care unit for the management of severe sepsis that was secondary to an inaugural toxic megacolon complicating a silent inflammatory bowel disease, with a Lichtiger score of 11. Nonresponse to anti-bacterial therapy, noradrenaline, and intravenous corticosteroid therapy required an emergency total colectomy. After surgery, the patient died because of his unresolved septic shock. Correct management of this condition requires an accurate assessment of the patient's history, a correct physical examination, abdominal radiographs, and sigmoid coloscopy, and frequently requires surgery. The indications for surgery in cases of toxic megacolon, massive hemorrhage, perforation, peritonitis, or non-response to medical therapy are the most important ones. Patients with a history of inflammatory bowel disease are particularly prone to infectious complications since therapy for these inflammatory diseases is based on the use of immunosuppressive drugs and frequent abdominal surgeries.
Insights
This case report details a fatal outcome of toxic megacolon (TM) in a patient with undiagnosed inflammatory bowel disease (IBD). Early surgical intervention is crucial for TM, a severe IBD complication, to prevent mortality.
Area of Science:
- Gastroenterology
- Critical Care Medicine
Background:
- Inflammatory bowel disease (IBD) can lead to severe complications like toxic megacolon (TM).
- TM is a life-threatening condition associated with high morbidity and mortality.
- Immunosuppressive therapy for IBD increases susceptibility to infectious complications.
Observation:
- A 49-year-old male presented with severe sepsis secondary to an inaugural toxic megacolon complicating silent IBD.
- The patient had a Lichtiger score of 11, indicating severe disease.
- Despite antibacterial therapy, noradrenaline, and corticosteroids, the patient did not improve.
Findings:
- Emergency total colectomy was performed due to non-response to medical management.
- The patient died post-surgery from unresolved septic shock.
- This case highlights the critical nature of TM and its potential for fatal outcomes.
Implications:
- Accurate assessment, including history, physical examination, imaging, and endoscopy, is vital for TM diagnosis.
- Surgical intervention is indicated for toxic megacolon with massive hemorrhage, perforation, peritonitis, or medical non-response.
- Prompt surgical management may improve outcomes in severe TM cases complicating IBD.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...